A Post Marketing Surveillance to Evaluate the Safety of Desidustat for the Treatment of Anemia in Subjects With Chronic Kidney Disease (CKD).(Real World Evidence Study)
PHASE4RecruitingINTERVENTIONAL
Enrollment
1,004
Participants
Timeline
Start Date
April 20, 2023
Primary Completion Date
June 30, 2025
Study Completion Date
November 30, 2025
Conditions
Chronic Kidney DiseasesAnemia of Chronic Kidney Disease
Interventions
DRUG
Desidustat
Oral tablet
Trial Locations (1)
800014
RECRUITING
Indira Gandhi Institute of Medical Sciences, Sheikhpura